Dhanuka Agritech: Business Overview & Financial Analysis
Dhanuka Agritech Limited is an Indian agrochemical manufacturing enterprise headquartered in Gurugram, Haryana. Promoted by Ram Gopal Agarwal and the Agarwal family, the company manufactures and markets crop protection chemicals including insecticides, fungicides, herbicides, and plant growth regulators (PGRs). Operating formulation manufacturing complexes in Sanand (Gujarat), Udhampur (Jammu & Kashmir), Keshwana (Rajasthan), and a chemical synthesis plant at Dahej (Gujarat), the enterprise distributes product solutions to Indian farmers through a pan-India rural dealer network.
Category Revenue Breakdown of Dhanuka Agritech (FY2026)
Dhanuka Agritech structures its operational crop protection sales across primary agrochemical product segments.
- Insecticides Division Share – 38.0% of Total Operating Revenue
- Herbicides Division Share – 32.0% of Total Operating Revenue
- Fungicides Division Share – 18.0% of Total Operating Revenue
- Plant Growth Regulators & Biologicals Share – 12.0% of Total Operating Revenue
Insecticides and herbicides represent seven-tenths of total corporate turnover, supplying pest management solutions for rice, cotton, and soybean crops. Specialty fungicides and bio-stimulants expand high-margin portfolio sales.
Product Portfolio & 9(3) Specialty Innovations of Dhanuka Agritech (FY2026)
The company categorizes its crop protection product portfolio into proprietary 9(3) molecules, co-marketed brands, and generic formulations.
- Proprietary 9(3) Molecule Products Share – 26.0% of Total Operating Revenue
- Innovation-Turnover Index Realisation – 13.9% of turnover generated from products launched in the last 5 years
- Flagship Brand Portfolio Roster – 'Targa Super', 'Sempra', 'Cover', 'Conika', and 'Decis'
- Strategic Global Tech Partners Roster – Nissan Chemical, Mitsui Chemicals, Sumitomo Chemical, and Bayer CropScience
Generating 26% of revenue from high-margin 9(3) specialty products provides brand differentiation. Technology tie-ups with global agrochemical leaders such as Nissan, Mitsui, Sumitomo, and Bayer enable the introduction of patented chemistries into India.
Distribution Network & Pan-India Reach of Dhanuka Agritech (Q1 FY2027)
Dhanuka Agritech operates a multi-tier distribution ecosystem servicing retail agronomists, distributors, and farming communities.
- Direct Primary Distributors Base – 6,500+ primary channel distributors
- Retail Touchpoints Reach Scale – 80,000+ retail dealer outlets across rural India
- Active Farmer Community Outreach Base – 10+ million farming households reached via field demonstrations
- Regional Distribution Warehouses Base – 41 operational company warehouses across Indian states
Operating a distribution network of 6,500+ primary distributors and 80,000+ retail touchpoints ensures product availability across core agricultural belts. Running 41 regional distribution warehouses optimizes stock replenishment during peak cropping seasons.
Manufacturing Complexes & Facility Scale of Dhanuka Agritech (Q1 FY2027)
The enterprise operates liquid, powder, granule formulation complexes, and a greenfield technical synthesis plant in Gujarat.
- Total Operational Manufacturing Facilities Base – 4 manufacturing plants across Rajasthan, J&K, and Gujarat
- Sanand & Keshwana Plants Role – Liquid, powder, and granule formulation manufacturing units
- Dahej (Gujarat) Chemical Synthesis Plant – Technical-grade active ingredient manufacturing plant
- Dahej Plant Revenue Realisation – Rs 50.00 crore in FY2026 (Projected to reach Rs 75.00 crore in FY2027)
Operating dedicated formulation units in Sanand, Udhampur, and Keshwana supports product packaging flexibility. Ramping up technical-grade manufacturing at the Dahej synthesis plant strengthens backward integration for key active ingredients.
Latest Quarterly Financial Performance of Dhanuka Agritech (Q1 FY2027)
Dhanuka Agritech recorded top-line revenue contraction and bottom-line margin pressure during the first quarter of FY2027 due to erratic rainfall and delayed acreage sowing.
- Consolidated Revenue from Operations – Rs 461.90 crore (-12.6% YoY vs Rs 528.30 crore in Q1 FY2026)
- Consolidated Operating EBITDA – Rs 55.00 crore (-33.9% YoY vs Rs 83.20 crore in Q1 FY2026)
- Consolidated Operating EBITDA Margin – 11.90% (-380 bps YoY vs 15.70%)
- Consolidated Net Profit After Tax (PAT) – Rs 36.30 crore (-34.6% YoY vs Rs 55.50 crore in Q1 FY2026)
- Standalone Net Profit After Tax (PAT) – Rs 35.80 crore
First-quarter consolidated operating revenue declined 12.6% year-on-year to Rs 461.90 crore, impacted by delayed monsoon onset and channel destocking. Consolidated Net Profit After Tax stood at Rs 36.30 crore, while operating EBITDA margins contracted to 11.90%.
Consolidated Annual Financial Performance of Dhanuka Agritech (FY2026)
The company achieved full-year turnover stability and profit conversion during full financial year FY2026.
- Full Year Consolidated Revenue from Operations – Rs 2,019.80 crore (-0.8% YoY vs Rs 2,035.20 crore in FY2025)
- Full Year Consolidated Operating EBITDA – Rs 403.96 crore (-3.0% YoY)
- Full Year Operating EBITDA Margin – 20.00% (-50 bps YoY)
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 287.24 crore (-3.3% YoY vs Rs 296.96 crore in FY2025)
- Return on Capital Employed (ROCE) Realisation – 24.80%
- Return on Equity (ROE) Realisation – 21.08%
Full-year operating turnover reached Rs 2,019.80 crore in FY2026, as consolidated Net Profit After Tax stood at Rs 287.24 crore. Delivering a return on equity of 21.08% reflects capital efficiency across formulation plants.
Balance Sheet Structure & Capital Health Ratios of Dhanuka Agritech (Q1 FY2027)
Dhanuka Agritech operates a net debt-free financial structure backed by equity net worth, cash flow generation, and share buybacks.
- Financial Debt Status – Net Debt-Free / Net Cash Surplus Capital Structure
- Completed Share Buyback Milestone – Completed Rs 70.00 crore share buyback at Rs 1,400 per share in July 2026
- Cash, Bank Balances & Liquid Treasury Holdings – ~Rs 480.00 crore
- Total Consolidated Shareholder Equity Net Worth Base – ~Rs 1,420.00 crore
Operating a net debt-free balance sheet with ~Rs 480.00 crore in treasury holdings provides balance sheet flexibility. Completing a Rs 70.00 crore share buyback in July 2026 expanded equity capital distributions to shareholders.
Nagpur Plant Capex & Product Launch Roadmap of Dhanuka Agritech (FY2027–FY2028)
The enterprise executes a strategic capital investment plan to construct a greenfield formulation plant in Nagpur and launch new crop protection chemistries.
- Nagpur Greenfield Formulation Plant Outlay – Rs 200.00 crore planned capex outlay for new formulation capacity
- Biologicals & Bio-Stimulants Revenue Guidance – Target to scale bio-stimulant turnover to Rs 130.00 crore in FY2027
- Bayer Products Licensing Revenue Guidance – Expected to generate ~Rs 60.00 crore in FY2027 before full-scale FY2028 rollout
- Annual Maintenance Capex Guidance – Rs 30.00 to Rs 40.00 crore per annum
- Funding Strategy – 100% funded through internal operational cash accruals
Allocating Rs 200.00 crore toward a new formulation plant in Nagpur expands supply reach across Central and Western Indian markets. Commercializing licensed Bayer chemistries and bio-stimulants supports product portfolio expansion.
Strategic Outlook & Management Commentary of Dhanuka Agritech (Q1 FY2027 Concall)
Management guidance outlines strategic priorities centered on double-digit volume growth, Dahej plant ramp-up, and 9(3) product scaling.
- Management targets maintaining a low double-digit top-line revenue growth rate for full financial year FY2027.
- Consolidated operating EBITDA margins are guided to sustain around the 19.0% to 20.0% corridor.
- Dahej technical synthesis plant revenue target is set at Rs 75.00 crore for FY2027.
- Proprietary 9(3) product category revenue contribution share is targeted to remain in the 25% to 26% range.
- Biologicals and bio-stimulants segment is projected to recover past Rs 130.00 crore following regulatory compliance approvals.
- Capital allocation strategy will prioritize self-funded plant additions and shareholder returns while preserving a debt-free balance sheet.
Management anticipates monsoon recovery in Q2 FY2027 to drive crop protection product off-take across agricultural states. Operational focus centers on commercializing new 9(3) chemistries, ramping up the Dahej synthesis plant, and preserving balance sheet health.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Dhanuka Agritech Limited Q1 FY2027 Financial Disclosures & Board Outcomes
- Dhanuka Agritech Limited Q1 FY2027 Investor Presentation & Concall Summary
- Public Notice & Disclosures for Rs 70 Crore Share Buyback
- Financial Results & Annual Performance Updates for Dhanuka Agritech Limited
- Ticker Finology Dhanuka Agritech Page
Disclaimer
The information presented above on Dhanuka Agritech has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Dhanuka Agritech page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.